The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 9

More JCP Articles

JCP
Neurosteroids and Postpartum Depression
Insights

October 7, 2024

In this video, Samantha Meltzer-Brody, MD, MPH, discusses the use of brexanolone and zuranolone, novel neurosteroids for treating postpartum depression, focusing on their mechanisms, rapid efficacy, and clinical trial…
JCP
Ketamine/Esketamine in Bipolar Depression in a Clinical Setting
Original Research

October 2, 2024

In a small sample of patients with bipolar depression treated with ketamine/esketamine, no evidence of mania or hypomania was seen during acute treatment.
, , , et al
JCP
Suicide Risk Evaluation and Advanced AI Models
Original Research

October 2, 2024

This study explored how ChatGPT-3.5 and ChatGPT-4 assess suicide risk factors like previous attempts, gender, and age, focusing on their predictions about different types of suicidal behavior.
, ,
JCP
Algorithms for TRD Treatment Success
Insights

September 27, 2024

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain…
JCP
Auvelity: A Rapid-Acting Antidepressant With Multimodal Activity
Information from Industry

September 27, 2024

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY…
JCP
Emerging Approaches in Schizophrenia
Educational Activity

September 26, 2024

This collection from Psychiatrist.com News highlights the latest developments in schizophrenia treatment, emphasizing new therapies that go beyond traditional dopaminergic approaches. Clinicians will gain insights into managing symptoms, cognitive…
JCP
Regression: Understanding What Covariates and Confounds Do in Adjusted Analyses
Clinical and Practical Psychopharmacology

September 18, 2024

Basic terms and concepts of regression analysis are presented, as well as three useful examples that involve readers in learning how regressions work.
JCP
Diagnostic Assessment via Telehealth vs Face-to-Face
Systematic Review

September 16, 2024

Several small studies suggest that telehealth holds promise for psychiatric assessments, especially when in-person evaluations are not feasible.
, , , et al
JCP
Medication Use and Lines of Treatment in Patients With Insomnia Disorder
Original Research

September 11, 2024

In this Canadian study, the annual cost of medications for insomnia was $54.8 million, and $30.3 million (55.2%) met inappropriate medication use criteria.
, , , et al
JCP
Bridge Symptoms Between Borderline Personality and PTSD
Original Research

September 9, 2024

Self-aggression, feelings of emptiness, dissociation, and feelings of detachment were found to be bridge symptoms between borderline personality disorder and PTSD. Targeting these might allow better prevention and management…
, , , et al
JCP
Collaborative vs Specialty Care for Depression or Anxiety
Original Research

September 4, 2024

Model effects at 6 months revealed that patients assigned to collaborative care showed significantly greater improvement than those assigned to specialty psychiatry.
, , , et al
JCP
Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine
Original Research

September 4, 2024

This study suggests that cognitive function does not moderate depression outcomes in vortioxetine, with results comparable to other antidepressants.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe